APO Research

APO RESEARCH · REPORT

Drug Detection and Analysis

Selected research

Industry Growth & Trends

Global Drug Detection and Analysis Industry Growth and Trends Forecast to 2032

Market perspective

According to APO Research, the global Drug Detection and Analysis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Drug Detection and Analysis is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Drug Detection and Analysis is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drug Detection and Analysis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Drug Detection and Analysis market include Eurofins Scientific, SGS, Labcorp, Intertek, WuXi AppTec, Charles River Laboratories, ICON pIc, IQVIA and Medpace, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Drug Detection and Analysis market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Drug Detection and Analysis market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Drug Detection and Analysis market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Drug Detection and Analysis.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Drug Detection and Analysis market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Drug Detection and Analysis Market by Company

Eurofins Scientific

SGS

Labcorp

Intertek

WuXi AppTec

Charles River Laboratories

ICON pIc

IQVIA

Medpace

Syneos Health

Frontage Laboratories

Pace Analytical Services

Element Materials Technology

ALS Limited

STERIS

LGC Limited

Almac Group

Catalent

Cambrex

Alcami

Toxikon

Boston Analytical

Drug Detection and Analysis Segment by Type

Chemical Drug Testing

Biopharmaceutical Testing

Traditional Chinese Medicine Testing

Others

Drug Detection and Analysis Segment by Application

Pharmaceutical Companies

Biopharmaceutical Companies

Drug Regulatory Authorities

Others

Drug Detection and Analysis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Detection and Analysis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Detection and Analysis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Detection and Analysis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Drug Detection and Analysis companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Drug Detection and Analysis Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Drug Detection and Analysis Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Drug Detection and Analysis Market Share by Region (2021-2026) Table 4. Global Drug Detection and Analysis Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Drug Detection and Analysis Market Share by Region (2027-2032) Table 6. Global Drug Detection and Analysis Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Drug Detection and Analysis Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Drug Detection and Analysis Market Size Share by Type (2021-2026) Table 9. Global Drug Detection and Analysis Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Drug Detection and Analysis Market Size Share Forecasted by Type (2027-2032) Table 11. North America Drug Detection and Analysis Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Drug Detection and Analysis Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Drug Detection and Analysis Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Drug Detection and Analysis Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Drug Detection and Analysis Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Drug Detection and Analysis Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Drug Detection and Analysis Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Drug Detection and Analysis Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Drug Detection and Analysis Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Drug Detection and Analysis Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Drug Detection and Analysis Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Drug Detection and Analysis Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Drug Detection and Analysis Market Size Share by Application (2021-2026) Table 24. Global Drug Detection and Analysis Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Drug Detection and Analysis Market Size Share Forecasted by Application (2027-2032) Table 26. North America Drug Detection and Analysis Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Drug Detection and Analysis Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Drug Detection and Analysis Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Drug Detection and Analysis Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Drug Detection and Analysis Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Drug Detection and Analysis Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Drug Detection and Analysis Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Drug Detection and Analysis Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Drug Detection and Analysis Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Drug Detection and Analysis Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Drug Detection and Analysis Industry Trends Table 37. Drug Detection and Analysis Industry Drivers Table 38. Drug Detection and Analysis Industry Opportunities and Challenges Table 39. Drug Detection and Analysis Industry Restraints Table 40. Global Drug Detection and Analysis Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Drug Detection and Analysis Revenue Market Share by Company (2021-2026) Table 42. Global Drug Detection and Analysis Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Drug Detection and Analysis Key Company Headquarters & Area Served Table 44. Global Drug Detection and Analysis Company, Product Type & Application Table 45. Global Drug Detection and Analysis Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Drug Detection and Analysis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Eurofins Scientific Company Information Table 49. Eurofins Scientific Business Overview Table 50. Eurofins Scientific Drug Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Eurofins Scientific Drug Detection and Analysis Product Portfolio Table 52. Eurofins Scientific Recent Development Table 53. SGS Company Information Table 54. SGS Business Overview Table 55. SGS Drug Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. SGS Drug Detection and Analysis Product Portfolio Table 57. SGS Recent Development Table 58. Labcorp Company Information Table 59. Labcorp Business Overview Table 60. Labcorp Drug Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Labcorp Drug Detection and Analysis Product Portfolio Table 62. Labcorp Recent Development Table 63. Intertek Company Information Table 64. Intertek Business Overview Table 65. Intertek Drug Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Intertek Drug Detection and Analysis Product Portfolio Table 67. Intertek Recent Development Table 68. WuXi AppTec Company Information Table 69. WuXi AppTec Business Overview Table 70. WuXi AppTec Drug Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. WuXi AppTec Drug Detection and Analysis Product Portfolio Table 72. WuXi AppTec Recent Development Table 73. Charles River Laboratories Company Information Table 74. Charles River Laboratories Business Overview Table 75. Charles River Laboratories Drug Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Charles River Laboratories Drug Detection and Analysis Product Portfolio Table 77. Charles River Laboratories Recent Development Table 78. ICON pIc Company Information Table 79. ICON pIc Business Overview Table 80. ICON pIc Drug Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. ICON pIc Drug Detection and Analysis Product Portfolio Table 82. ICON pIc Recent Development Table 83. IQVIA Company Information Table 84. IQVIA Business Overview Table 85. IQVIA Drug Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. IQVIA Drug Detection and Analysis Product Portfolio Table 87. IQVIA Recent Development Table 88. Medpace Company Information Table 89. Medpace Business Overview Table 90. Medpace Drug Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Medpace Drug Detection and Analysis Product Portfolio Table 92. Medpace Recent Development Table 93. Syneos Health Company Information Table 94. Syneos Health Business Overview Table 95. Syneos Health Drug Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Syneos Health Drug Detection and Analysis Product Portfolio Table 97. Syneos Health Recent Development Table 98. Frontage Laboratories Company Information Table 99. Frontage Laboratories Business Overview Table 100. Frontage Laboratories Drug Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Frontage Laboratories Drug Detection and Analysis Product Portfolio Table 102. Frontage Laboratories Recent Development Table 103. Pace Analytical Services Company Information Table 104. Pace Analytical Services Business Overview Table 105. Pace Analytical Services Drug Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Pace Analytical Services Drug Detection and Analysis Product Portfolio Table 107. Pace Analytical Services Recent Development Table 108. Element Materials Technology Company Information Table 109. Element Materials Technology Business Overview Table 110. Element Materials Technology Drug Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Element Materials Technology Drug Detection and Analysis Product Portfolio Table 112. Element Materials Technology Recent Development Table 113. ALS Limited Company Information Table 114. ALS Limited Business Overview Table 115. ALS Limited Drug Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. ALS Limited Drug Detection and Analysis Product Portfolio Table 117. ALS Limited Recent Development Table 118. STERIS Company Information Table 119. STERIS Business Overview Table 120. STERIS Drug Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. STERIS Drug Detection and Analysis Product Portfolio Table 122. STERIS Recent Development Table 123. LGC Limited Company Information Table 124. LGC Limited Business Overview Table 125. LGC Limited Drug Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. LGC Limited Drug Detection and Analysis Product Portfolio Table 127. LGC Limited Recent Development Table 128. Almac Group Company Information Table 129. Almac Group Business Overview Table 130. Almac Group Drug Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Almac Group Drug Detection and Analysis Product Portfolio Table 132. Almac Group Recent Development Table 133. Catalent Company Information Table 134. Catalent Business Overview Table 135. Catalent Drug Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Catalent Drug Detection and Analysis Product Portfolio Table 137. Catalent Recent Development Table 138. Cambrex Company Information Table 139. Cambrex Business Overview Table 140. Cambrex Drug Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Cambrex Drug Detection and Analysis Product Portfolio Table 142. Cambrex Recent Development Table 143. Alcami Company Information Table 144. Alcami Business Overview Table 145. Alcami Drug Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Alcami Drug Detection and Analysis Product Portfolio Table 147. Alcami Recent Development Table 148. Toxikon Company Information Table 149. Toxikon Business Overview Table 150. Toxikon Drug Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Toxikon Drug Detection and Analysis Product Portfolio Table 152. Toxikon Recent Development Table 153. Boston Analytical Company Information Table 154. Boston Analytical Business Overview Table 155. Boston Analytical Drug Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. Boston Analytical Drug Detection and Analysis Product Portfolio Table 157. Boston Analytical Recent Development Table 158. North America Drug Detection and Analysis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. North America Drug Detection and Analysis Market Size by Country (2021-2026) & (US$ Million) Table 160. North America Drug Detection and Analysis Market Share by Country (2021-2026) Table 161. North America Drug Detection and Analysis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. North America Drug Detection and Analysis Market Share Forecast by Country (2027-2032) Table 163. Europe Drug Detection and Analysis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Europe Drug Detection and Analysis Market Size by Country (2021-2026) & (US$ Million) Table 165. Europe Drug Detection and Analysis Market Share by Country (2021-2026) Table 166. Europe Drug Detection and Analysis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Europe Drug Detection and Analysis Market Share Forecast by Country (2027-2032) Table 168. Asia-Pacific Drug Detection and Analysis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Asia-Pacific Drug Detection and Analysis Market Size by Country (2021-2026) & (US$ Million) Table 170. Asia-Pacific Drug Detection and Analysis Market Share by Country (2021-2026) Table 171. Asia-Pacific Drug Detection and Analysis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Asia-Pacific Drug Detection and Analysis Market Share Forecast by Country (2027-2032) Table 173. Latin America Drug Detection and Analysis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Latin America Drug Detection and Analysis Market Size by Country (2021-2026) & (US$ Million) Table 175. Latin America Drug Detection and Analysis Market Share by Country (2021-2026) Table 176. Latin America Drug Detection and Analysis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Latin America Drug Detection and Analysis Market Share Forecast by Country (2027-2032) Table 178. Middle East & Africa Drug Detection and Analysis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Middle East & Africa Drug Detection and Analysis Market Size by Country (2021-2026) & (US$ Million) Table 180. Middle East & Africa Drug Detection and Analysis Market Share by Country (2021-2026) Table 181. Middle East & Africa Drug Detection and Analysis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Middle East & Africa Drug Detection and Analysis Market Share Forecast by Country (2027-2032) Table 183. Research Programs/Design for This Report Table 184. Authors List of This Report Table 185. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Drug Detection and Analysis Product Image Figure 3. Global Drug Detection and Analysis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Drug Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 5. Global Drug Detection and Analysis Market Share by Region: 2025 VS 2032 Figure 6. Global Drug Detection and Analysis Market Share by Region (2021-2032) Figure 7. North America Drug Detection and Analysis Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Drug Detection and Analysis Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Drug Detection and Analysis Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Drug Detection and Analysis Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Drug Detection and Analysis Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Chemical Drug Testing Image Figure 13. Global Chemical Drug Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Biopharmaceutical Testing Image Figure 15. Global Biopharmaceutical Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Traditional Chinese Medicine Testing Image Figure 17. Global Traditional Chinese Medicine Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Drug Detection and Analysis Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Drug Detection and Analysis Market Share by Type 2025 VS 2032 Figure 22. North America Drug Detection and Analysis Market Size Share by Type (2021-2032) Figure 23. Europe Drug Detection and Analysis Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Drug Detection and Analysis Market Size Share by Type (2021-2032) Figure 25. Latin America Drug Detection and Analysis Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Drug Detection and Analysis Market Size Share by Type (2021-2032) Figure 27. Pharmaceutical Companies Image Figure 28. Global Pharmaceutical Companies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Biopharmaceutical Companies Image Figure 30. Global Biopharmaceutical Companies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Drug Regulatory Authorities Image Figure 32. Global Drug Regulatory Authorities Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Others Image Figure 34. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Drug Detection and Analysis Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Drug Detection and Analysis Market Share by Application 2025 VS 2032 Figure 37. North America Drug Detection and Analysis Market Size Share by Application (2021-2032) Figure 38. Europe Drug Detection and Analysis Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Drug Detection and Analysis Market Size Share by Application (2021-2032) Figure 40. Latin America Drug Detection and Analysis Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Drug Detection and Analysis Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Drug Detection and Analysis Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Drug Detection and Analysis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Drug Detection and Analysis Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Drug Detection and Analysis Market Share by Country (2021-2032) Figure 47. Europe Drug Detection and Analysis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Drug Detection and Analysis Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Drug Detection and Analysis Market Share by Country (2021-2032) Figure 50. Asia-Pacific Drug Detection and Analysis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Drug Detection and Analysis Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Drug Detection and Analysis Market Share by Country (2021-2032) Figure 53. Latin America Drug Detection and Analysis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Drug Detection and Analysis Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Drug Detection and Analysis Market Share by Country (2021-2032) Figure 56. Middle East & Africa Drug Detection and Analysis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Drug Detection and Analysis Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Drug Detection and Analysis Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Chemical Drug Testing
  • Biopharmaceutical Testing
  • Traditional Chinese Medicine Testing
  • Others
Applications
  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Drug Regulatory Authorities
  • Others
Companies covered
  • Eurofins Scientific
  • SGS
  • Labcorp
  • Intertek
  • WuXi AppTec
  • Charles River Laboratories
  • ICON pIc
  • IQVIA
  • Medpace
  • Syneos Health
  • Frontage Laboratories
  • Pace Analytical Services
  • Element Materials Technology
  • ALS Limited
  • STERIS
  • LGC Limited
  • Almac Group
  • Catalent
  • Cambrex
  • Alcami
  • Toxikon
  • Boston Analytical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Drug Detection and Analysis Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Drug Detection and Analysis Market Size by Region (2021-2032)
  5. 1.4.1 Global Drug Detection and Analysis Market Size by Region (2021-2026)
  6. 1.4.2 Global Drug Detection and Analysis Market Size by Region (2027-2032)
  7. 1.5 Key Regions Drug Detection and Analysis Market Size (2021-2032)
  8. 1.5.1 North America Drug Detection and Analysis Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Drug Detection and Analysis Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Drug Detection and Analysis Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Drug Detection and Analysis Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Drug Detection and Analysis Market Size Growth Rate (2021-2032)
2 Drug Detection and Analysis Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Chemical Drug Testing
  3. 2.1.2 Biopharmaceutical Testing
  4. 2.1.3 Traditional Chinese Medicine Testing
  5. 2.1.4 Others
  6. 2.2 Global Drug Detection and Analysis Market Size by Type
  7. 2.2.1 Global Drug Detection and Analysis Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Drug Detection and Analysis Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Drug Detection and Analysis Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Drug Detection and Analysis Market Size by Regions
  11. 2.3.1 North America Drug Detection and Analysis Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Drug Detection and Analysis Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Drug Detection and Analysis Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Drug Detection and Analysis Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Drug Detection and Analysis Market Size Breakdown by Type (2021-2026)
3 Drug Detection and Analysis Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Pharmaceutical Companies
  3. 3.1.2 Biopharmaceutical Companies
  4. 3.1.3 Drug Regulatory Authorities
  5. 3.1.4 Others
  6. 3.2 Global Drug Detection and Analysis Market Size by Application
  7. 3.2.1 Global Drug Detection and Analysis Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Drug Detection and Analysis Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Drug Detection and Analysis Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Drug Detection and Analysis Market Size by Regions
  11. 3.3.1 North America Drug Detection and Analysis Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Drug Detection and Analysis Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Drug Detection and Analysis Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Drug Detection and Analysis Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Drug Detection and Analysis Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Drug Detection and Analysis Industry Trends
  2. 4.2 Drug Detection and Analysis Industry Drivers
  3. 4.3 Drug Detection and Analysis Industry Opportunities and Challenges
  4. 4.4 Drug Detection and Analysis Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Drug Detection and Analysis Revenue (2021-2026)
  2. 5.2 Global Drug Detection and Analysis Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Drug Detection and Analysis Key Company Headquarters & Area Served
  4. 5.4 Global Drug Detection and Analysis Company, Product Type & Application
  5. 5.5 Global Drug Detection and Analysis Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Drug Detection and Analysis Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Drug Detection and Analysis Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Drug Detection and Analysis Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Eurofins Scientific
  2. 6.1.1 Eurofins Scientific Company Information
  3. 6.1.2 Eurofins Scientific Business Overview
  4. 6.1.3 Eurofins Scientific Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Eurofins Scientific Drug Detection and Analysis Product Portfolio
  6. 6.1.5 Eurofins Scientific Recent Developments
  7. 6.2 SGS
  8. 6.2.1 SGS Company Information
  9. 6.2.2 SGS Business Overview
  10. 6.2.3 SGS Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 SGS Drug Detection and Analysis Product Portfolio
  12. 6.2.5 SGS Recent Developments
  13. 6.3 Labcorp
  14. 6.3.1 Labcorp Company Information
  15. 6.3.2 Labcorp Business Overview
  16. 6.3.3 Labcorp Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Labcorp Drug Detection and Analysis Product Portfolio
  18. 6.3.5 Labcorp Recent Developments
  19. 6.4 Intertek
  20. 6.4.1 Intertek Company Information
  21. 6.4.2 Intertek Business Overview
  22. 6.4.3 Intertek Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Intertek Drug Detection and Analysis Product Portfolio
  24. 6.4.5 Intertek Recent Developments
  25. 6.5 WuXi AppTec
  26. 6.5.1 WuXi AppTec Company Information
  27. 6.5.2 WuXi AppTec Business Overview
  28. 6.5.3 WuXi AppTec Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 WuXi AppTec Drug Detection and Analysis Product Portfolio
  30. 6.5.5 WuXi AppTec Recent Developments
  31. 6.6 Charles River Laboratories
  32. 6.6.1 Charles River Laboratories Company Information
  33. 6.6.2 Charles River Laboratories Business Overview
  34. 6.6.3 Charles River Laboratories Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Charles River Laboratories Drug Detection and Analysis Product Portfolio
  36. 6.6.5 Charles River Laboratories Recent Developments
  37. 6.7 ICON pIc
  38. 6.7.1 ICON pIc Company Information
  39. 6.7.2 ICON pIc Business Overview
  40. 6.7.3 ICON pIc Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 ICON pIc Drug Detection and Analysis Product Portfolio
  42. 6.7.5 ICON pIc Recent Developments
  43. 6.8 IQVIA
  44. 6.8.1 IQVIA Company Information
  45. 6.8.2 IQVIA Business Overview
  46. 6.8.3 IQVIA Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 IQVIA Drug Detection and Analysis Product Portfolio
  48. 6.8.5 IQVIA Recent Developments
  49. 6.9 Medpace
  50. 6.9.1 Medpace Company Information
  51. 6.9.2 Medpace Business Overview
  52. 6.9.3 Medpace Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Medpace Drug Detection and Analysis Product Portfolio
  54. 6.9.5 Medpace Recent Developments
  55. 6.10 Syneos Health
  56. 6.10.1 Syneos Health Company Information
  57. 6.10.2 Syneos Health Business Overview
  58. 6.10.3 Syneos Health Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Syneos Health Drug Detection and Analysis Product Portfolio
  60. 6.10.5 Syneos Health Recent Developments
  61. 6.11 Frontage Laboratories
  62. 6.11.1 Frontage Laboratories Company Information
  63. 6.11.2 Frontage Laboratories Business Overview
  64. 6.11.3 Frontage Laboratories Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Frontage Laboratories Drug Detection and Analysis Product Portfolio
  66. 6.11.5 Frontage Laboratories Recent Developments
  67. 6.12 Pace Analytical Services
  68. 6.12.1 Pace Analytical Services Company Information
  69. 6.12.2 Pace Analytical Services Business Overview
  70. 6.12.3 Pace Analytical Services Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Pace Analytical Services Drug Detection and Analysis Product Portfolio
  72. 6.12.5 Pace Analytical Services Recent Developments
  73. 6.13 Element Materials Technology
  74. 6.13.1 Element Materials Technology Company Information
  75. 6.13.2 Element Materials Technology Business Overview
  76. 6.13.3 Element Materials Technology Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Element Materials Technology Drug Detection and Analysis Product Portfolio
  78. 6.13.5 Element Materials Technology Recent Developments
  79. 6.14 ALS Limited
  80. 6.14.1 ALS Limited Company Information
  81. 6.14.2 ALS Limited Business Overview
  82. 6.14.3 ALS Limited Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 ALS Limited Drug Detection and Analysis Product Portfolio
  84. 6.14.5 ALS Limited Recent Developments
  85. 6.15 STERIS
  86. 6.15.1 STERIS Company Information
  87. 6.15.2 STERIS Business Overview
  88. 6.15.3 STERIS Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 STERIS Drug Detection and Analysis Product Portfolio
  90. 6.15.5 STERIS Recent Developments
  91. 6.16 LGC Limited
  92. 6.16.1 LGC Limited Company Information
  93. 6.16.2 LGC Limited Business Overview
  94. 6.16.3 LGC Limited Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 LGC Limited Drug Detection and Analysis Product Portfolio
  96. 6.16.5 LGC Limited Recent Developments
  97. 6.17 Almac Group
  98. 6.17.1 Almac Group Company Information
  99. 6.17.2 Almac Group Business Overview
  100. 6.17.3 Almac Group Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Almac Group Drug Detection and Analysis Product Portfolio
  102. 6.17.5 Almac Group Recent Developments
  103. 6.18 Catalent
  104. 6.18.1 Catalent Company Information
  105. 6.18.2 Catalent Business Overview
  106. 6.18.3 Catalent Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Catalent Drug Detection and Analysis Product Portfolio
  108. 6.18.5 Catalent Recent Developments
  109. 6.19 Cambrex
  110. 6.19.1 Cambrex Company Information
  111. 6.19.2 Cambrex Business Overview
  112. 6.19.3 Cambrex Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Cambrex Drug Detection and Analysis Product Portfolio
  114. 6.19.5 Cambrex Recent Developments
  115. 6.20 Alcami
  116. 6.20.1 Alcami Company Information
  117. 6.20.2 Alcami Business Overview
  118. 6.20.3 Alcami Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Alcami Drug Detection and Analysis Product Portfolio
  120. 6.20.5 Alcami Recent Developments
  121. 6.21 Toxikon
  122. 6.21.1 Toxikon Company Information
  123. 6.21.2 Toxikon Business Overview
  124. 6.21.3 Toxikon Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Toxikon Drug Detection and Analysis Product Portfolio
  126. 6.21.5 Toxikon Recent Developments
  127. 6.22 Boston Analytical
  128. 6.22.1 Boston Analytical Company Information
  129. 6.22.2 Boston Analytical Business Overview
  130. 6.22.3 Boston Analytical Drug Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 Boston Analytical Drug Detection and Analysis Product Portfolio
  132. 6.22.5 Boston Analytical Recent Developments
7 North America
  1. 7.1 North America Drug Detection and Analysis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Drug Detection and Analysis Market Size by Country (2021-2026)
  3. 7.3 North America Drug Detection and Analysis Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Drug Detection and Analysis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Drug Detection and Analysis Market Size by Country (2021-2026)
  3. 8.3 Europe Drug Detection and Analysis Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Drug Detection and Analysis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Drug Detection and Analysis Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Drug Detection and Analysis Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Drug Detection and Analysis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Drug Detection and Analysis Market Size by Country (2021-2026)
  3. 10.3 South America Drug Detection and Analysis Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Drug Detection and Analysis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Drug Detection and Analysis Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Drug Detection and Analysis Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research